Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Julia Rawlings

Concepts (54)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Safety Management
2
2018
112
0.670
Why?
Patient Safety
2
2018
287
0.560
Why?
Pharmacy Service, Hospital
1
2018
90
0.530
Why?
Organizational Culture
1
2018
138
0.530
Why?
Remote Consultation
1
2022
47
0.190
Why?
Drug Overdose
1
2022
322
0.150
Why?
Pharmacy
1
2017
31
0.130
Why?
Pharmaceutical Services
1
2017
81
0.130
Why?
Benchmarking
1
2017
176
0.120
Why?
Opioid-Related Disorders
1
2022
484
0.120
Why?
Pharmacists
1
2017
247
0.110
Why?
Colchicine
1
2012
24
0.100
Why?
Gout Suppressants
1
2012
17
0.100
Why?
Gout
1
2012
33
0.100
Why?
Hematologic Diseases
1
2012
61
0.100
Why?
Chemical and Drug Induced Liver Injury
1
2012
132
0.090
Why?
Renal Insufficiency
1
2012
149
0.090
Why?
Attitude of Health Personnel
1
2018
1098
0.080
Why?
Cross-Sectional Studies
2
2018
5066
0.080
Why?
Delivery of Health Care
1
2017
894
0.080
Why?
Surveys and Questionnaires
2
2018
5406
0.070
Why?
Sumatriptan
1
1999
8
0.040
Why?
Health Maintenance Organizations
1
1999
97
0.040
Why?
Colorado
2
2022
4421
0.040
Why?
Migraine Disorders
1
1999
101
0.030
Why?
Pharmacies
1
2017
36
0.030
Why?
Pain
1
2022
789
0.030
Why?
Analgesics, Opioid
1
2022
913
0.030
Why?
Humans
5
2022
129650
0.030
Why?
Practice Patterns, Physicians'
1
2022
1266
0.030
Why?
Counseling
1
2017
385
0.030
Why?
Cytochrome P-450 CYP3A Inhibitors
1
2012
18
0.020
Why?
Cytochrome P-450 CYP3A
1
2012
87
0.020
Why?
Insurance, Health, Reimbursement
1
2012
94
0.020
Why?
Drug Interactions
1
2012
394
0.020
Why?
Communication
1
2017
846
0.020
Why?
Enzyme Inhibitors
1
2012
827
0.020
Why?
United States
2
2022
13903
0.020
Why?
Prevalence
1
2012
2564
0.020
Why?
Electronic Health Records
1
2012
975
0.010
Why?
Case-Control Studies
1
2012
3381
0.010
Why?
Cohort Studies
1
2012
5420
0.010
Why?
Efficiency
1
1999
91
0.010
Why?
Health Services
1
1999
99
0.010
Why?
Statistics, Nonparametric
1
1999
422
0.010
Why?
Cost of Illness
1
1999
278
0.010
Why?
Young Adult
1
2012
12426
0.010
Why?
Middle Aged
2
2012
31154
0.010
Why?
Adult
2
2012
35576
0.010
Why?
Patient Satisfaction
1
1999
634
0.010
Why?
Aged
1
2012
22103
0.010
Why?
Male
2
2012
63681
0.010
Why?
Female
2
2012
68776
0.010
Why?
Quality of Life
1
1999
2704
0.000
Why?
Rawlings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)